Brown Advisory’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,000
Closed -$1K 1037
2019
Q3
$1K Buy
+1,000
New +$68.6K ﹤0.01% 1005

Other funds holding ABBV

Brown Advisory's ABBV Position: Q1 2026 in Review

Brown Advisory reduced its AbbVie (ABBV) stake by 0.02% in Q1 2026, selling an estimated $47K and leaving 874,731 shares worth $190M. The position accounts for 0.31% of the portfolio, ranked #70.

Brown Advisory first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $204M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Brown Advisory held 874,731 shares of AbbVie worth $190M as of Q1 2026.
  • Brown Advisory sold 212 AbbVie shares in Q1 2026, an estimated $47K.
  • AbbVie made up 0.31% of Brown Advisory's portfolio in Q1 2026, its #70 holding.
  • Brown Advisory first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Brown Advisory's AbbVie position peaked at $204M in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.